In vivo postantibiotic effect in a thigh infection in neutropenic mice

Journal of Infectious Diseases

Volumn 157, Issue 2, 1988, Pages 287-298

  Vogelman, B ^a,b   Gudmundsson, S ^a   Turnidge, J ^a   Leggett, J ^a   Craig, W A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFAMANDOLE; CEFAZOLIN; CEFOPERAZONE; CLINDAMYCIN; ERYTHROMYCIN GLUCOHEPTONATE; GENTAMICIN; NAFCILLIN; PENICILLIN G; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANIMAL EXPERIMENT; DRUG DOSE; DRUG THERAPY; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

AGRANULOCYTOSIS; ANIMAL; ANTIBIOTICS; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEMALE; KLEBSIELLA PNEUMONIAE; MICE; NEUTROPENIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; THIGH;

EID: 0023911161     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/157.2.287     Document Type: Article

References (45)

1. Kunin CM. Dosage schedules of antimicrobial agents: A his-torical review. Rev Infect Dis 1981;3:4-11
2. Jawetz E. Dynamics of the action of penicillin in experimental animals: Observations on mice. Arch Intern Med 1946;77:1-15
3. Schmidt LH, Walley A, Larson RD. The influence of the dosage regimen on the therapeutic activity of penicillin G. J Pharmacol Exp Ther 1949;96:258-68
4. Eagle H, Fleischman R, Musselman AD. Effect of schedule of administration on the therapeutic efficacy of penicillin. Importance of the aggregate time penicillin remains at effectively bactericidal levels. Am J Med 1950;9:280-99
5. Bigger JW. Bactericidal action of penicillin on Staphylococcus pyogenes. Ir J Med Sci 1944;227:553-85
6. Parker RF, Luse S. The action of penicillin on Staphylococcus: Further observations on the effect of a short exposure. J Bacteriol 1948;56:75-81
7. Eagle H. The recovery of bacteria from the toxic effects of penicillin. J Clin Invest 1949;28:832-6
8. McDonald PJ, Craig WA, Kunin CM. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J Infect Dis 1977;135:217-23
9. Bundtzen RW, Gerber AU, Cohn DL, Craig WA. Postantibiotic suppression of bacterial growth. Rev Infect Dis 1981;3:28-37
10. Gerber AU, Craig WA. Growth kinetics of respiratory pathogens after short exposures to ampicillin and erythromycininvitro. J Antimicrob Chemother 1981;8 (Suppl C):81-91
11. Vogelman BS, Craig WA. Postantibiotic effects. J Antimicrob Chemother 1985;15 (Suppl A):37-46
12. Craig WA, Gudmundsson S. The postantibiotic effect. In: Lorian V, ed. Antibiotics in laboratory medicine. 2nd ed. Baltimore: Wiliams and Wilkins, 1985:515-36
13. Bustamante CI, Drusano GL, Tatem BA, Standiford HC. Postantibiotic effect of imipenem on Pseudomonas aeruginosa. Antimicrob Agents Chemother 1984;26:678-82
14. Eagle H, Fleischman R, Musselman AD. The bactericidal action of penicillin in vivo: The participation of the host, and the slow recovery of the surviving organisms. Ann Intern Med 1950;33:544-71
15. Sande MA, Korzeniowski OM, Allegro GM, Brennan RO, Zak O, Scheld WM. Intermittent or continuous therapy of experimental meningitis due to Streptococcuspneumoniae in rabbits: Preliminary observations on the postantibiotic effect in vivo. Rev Infect Dis 1981;3:98-109
16. Tauber MG, Zak O, Scheld WM, Hengstler B, Sande MA. The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits. J Infect Dis 1984;149:575-83
17. Hunter PA, Rolinson GN, Witting DA. Comparative activity of amoxycillin and ampicillin in an experimental bacterial infection in mice. Antimicrob Agents Chemother 1973;4:285-93
18. Rolinson GN. Plasma concentrations of penicillin in relation to the antibacterial effect. In: Davies DS, Prichard BNC, eds. Biological effects of drugs in relation to their plasma concentrations. London: Macmillan Press, 1973: 183-9
19. Gerber AU, Vastola AP, Brandel J, Craig WA. Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model. J Infect Dis 1982;146:691-7
20. Gerber AU, Craig WA, Brugger H-P, Feller C, Vastola AP, Brandel J. Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice. J Infect Dis 1983;147:910-7
21. Edberg SC, Sabath LD. Determination of antibiotic levels in body fluids: Techniques and significance. Bactericidal tests in endocarditis and other severe infections. In: Lorian V, ed. Antibiotics in laboratory medicine. Baltimore: Williams and Wilkins, 1980:206-64
22. Gibaldi M, Perrier D. Pharmacokinetics. Vol. I. New York: Marcel Dekker, 1975 Rauws AG, van Klingeren B. Estimation of antibiotic levels in interstitial fluid from whole tissue levels. Scand J Infect Dis [Suppl] 1978;14:186-8
23. Ryan DM, Cars O. Antibiotic assays in muscle: Are conventional tissue levels misleading as indicator of the antibacterial activity? Scand J Infect Dis 1980;12:307-9
24. Tuomanen E. Newly made enzymes determine ongoing cell wall synthesis and the antibacterial effects of cell wall synthesis inhibitors. J Bacteriol 1986;167:535-43
25. Lorian V. Low concentrations of antibiotics. J Antimicrob Chemother 1985;15 (Suppl A):15-26
26. Gerber AU, Craig WA. Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa. Characterization and virulence in normal and leukopenic mice. J Lab Clin Med 1982;100:671-81
27. Haag R. Post-MIC effect of fosfomycin on Pseudomonas aeruginosa in vitro and in experimentally infected mice. J Antimicrob Chemother 1985;15 (Suppl A):265-71
28. Ingerman M J, Pitsakis PG, Rosenberg AF, Levison ME. The importance of pharmacodynamics in determining the dosing interval in therapy for experimental Pseudomonas endocarditis in the rat. J Infect Dis 1986;153:707-14
29. Trexler-Hessen M, Pitsakis PG, Levison ME. Pharmacodynamics of imipenem in experimental Pseudomonas aeruginosa endocarditis [abstract 292]. In: Program and abstracts of the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology 1986
30. Gudmundsson S, Vogelman B, Craig WA. The in vivo postantibiotic effect of imipenem and other new antimicrobials. J Antimicrob Chemother 1986;18 (Suppl E):67-73
31. Zak O, Kradolfer F. Effects of subminimal inhibitory concentrations of antibiotics in experimental infections. Rev Infect Dis 1979;1:862-79
32. McDonald PJ, Wetherall BL, Pruul H. Postantibiotic leukocyte enhancement: Increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes. Rev Infect Dis 1981;3:38-44
33. Eagle H, Fleischman R, Levy M. “Continuous” vs. “discontinuous” therapy with penicillin. The effect of the interval between injections on therapeutic efficacy. N Engl J Med 1953;248:481-8
34. Gudmundsson S, Turnidge J, Craig WA. Effect of different dosage regimens on in vivo efficacy of antibiotics against Klebsiella pneumoniae [abstract]. Clin Res 1982;30:777A
35. Roosendaal R, Bakker-Woudenberg IA, van den Berg JC, Michel MK. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats. J Infect Dis 1985;152:373-8
36. Bakker-Woudenberg IAJM, van den Berg JC, Fontijne P, Michel MF. Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodeficient rats. Eur J Clin Microbiol 1984;3:131-5
37. Mordenti JJ, Quintiliani R, Nightingale CH. Combination antibiotic therapy: Comparison of constant infusion and intermittent bolus dosing in an experimental animal model. J Antimicrob Chemother 1985;15 (Suppl A):313-21
38. Bodey GP, Ketchel SJ, Rodriguez VA. A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients. Am J Med 1979;67:608-16
39. Powell SH, Thompson WL, Luthe MA, Stern RC, Gross-niklaus DA, Bloxham DD, Groden DL, Jacobs MR, DiS- cenna AO, Cash HA, Klinger JD. Once-daily vs. continuous aminoglycoside dosing: Efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. J Infect Dis 1983;147:918-32
40. Gudmundsson S, Vogelman B, Leggett J, Craig W. Correlation of pharmacokinetic parameters with efficacy for cefazolin against Staphylococcus aureus and its relationship to the in vivo postantibiotic effect in an animal model. In: Ishigami J, ed. Recent advances in chemotherapy. Proceedings of the 14th International Congress of Chemotherapy, Kyoto, Japan, 1985. Tokyo: University of Tokyo Press, 1985:625-6
41. Kapusnik J, Hackbarth C, Chambers H, Scott K, Carpenter T, Sande M. Efficacy of once daily versus intermittent dosing of tobramycin in neutropenic and normal, sedated guinea pigs with experimental pseudomonas pneumonia [abstract 548]. In: Program and abstracts of the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1985
42. Feld R, Valdivieso M, Bodey GP, Rodriguez V. A comparative trial of sisomicin therapy by intermittent versus continuous infusion. Am J Med Sci 1977;274:179-88
43. Feld R, Rachlis A, Tuffnell PG, Duncan I, Moran L, Pinfold P, DeBoer G. Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandole. Arch Intern Med 1984;144:1005-10
44. Nördstrom L, Cronberg S, Ringberg H, Tjernstrom O, Walder M. Prospective, comparative, randomized clinical study of aminoglycosides given once a day versus three times a day in severe infections. In: Ishigami J, ed. Recent advances in chemotherapy. Proceedings of the 14th International Congress of Chemotherapy, Kyoto, 1985. Tokyo: University of Tokyo Press, 1985:2653-4
45. Gengo FM, Mannion TW, Nightingale CH, Schentag JJ. Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis. J Antimicrob Chemother 1984;14:619-31